Literature DB >> 28509107

Concurrent acute spontaneous tumor lysis syndrome complicated with multiple organ failure in a patient with pre-existing undiagnosed lung cancer.

Fateme Shamekhi Amiri1.   

Abstract

Acute kidney injury, a common complication associated with malignancy, occurs in various clinical situations for numerous reasons. Acute tumor lysis syndrome (TLS) is possibly the most significant cause of acute kidney injury in cancer patients, because it is fulminant at onset and associated with severe metabolic derangements. Acute spontaneous tumor lysis syndrome is rare and most of the related malignancies belong to hematologic malignancies but it has seldom been investigated as bulky or advanced metastatic non-hematologic malignancies. TLS comprises a clinical laboratory derangement of cellular metabolism which can lead to acute renal impairments, cardiac arrhythmia, seizures and patient demise. Prevention and treatment of tumor lysis syndrome depends on early recognition of at-risk patients, volume repletion and xanthin oxidase inhibitors. In addition, in patients with high risk tumor types, prophylactic use of rasburicase before chemotherapy is required. If dialysis is required, continuous modalities may be favored, particularly in patients with more severe TLS. This case report discusses a 79-year-old man with controlled Alzheimer's disease presented with picture of septic shock and multiorgan dysfunction (acute kidney injury, acute lung injury, acute brain injury) pulmonary suppuration in the right lung field due to aspiration pneumonia with infection-induced systemic inflammatory response (SIRS) was diagnosed. Further work-up revealed lung cancer on chest CT scan. Antibiotic, respirator and hemodialysis treatment improved his condition but died several days later. Acute spontaneous TLS may present in association with infectious SIRS and multiple organ failure, the combination of which results in significant mortality.

Entities:  

Keywords:  Lung cancer; Multiple organ failure; Spontaneous tumor lysis syndrome

Year:  2015        PMID: 28509107      PMCID: PMC5413772          DOI: 10.1007/s13730-015-0175-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

1.  Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.

Authors:  Anastasia Papadopoulou; Robert A Krance; Carl E Allen; Daniel Lee; Cliona M Rooney; Malcolm K Brenner; Ann M Leen; Helen E Heslop
Journal:  Mol Ther       Date:  2014-03-21       Impact factor: 11.454

Review 2.  Hormonal and cytokine effects of uric acid.

Authors:  Laura G Sánchez-Lozada; Takahiko Nakagawa; Duk-Hee Kang; Dan I Feig; Martha Franco; Richard J Johnson; Jaime Herrera-Acosta
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-01       Impact factor: 2.894

Review 3.  Acute kidney injury in the cancer patient.

Authors:  G Adam Campbell; Daniel Hu; Mark D Okusa
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

Review 4.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

Review 5.  Advances in the study of serum tumor markers of lung cancer.

Authors:  Wenjie Qi; Xuechang Li; Jingbo Kang
Journal:  J Cancer Res Ther       Date:  2014-11       Impact factor: 1.805

6.  Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.

Authors:  T Berghmans; M Paesmans; C Mascaux; B Martin; A-P Meert; A Haller; J-J Lafitte; J-P Sculier
Journal:  Ann Oncol       Date:  2006-09-15       Impact factor: 32.976

7.  Spontaneous tumor lysis syndrome in a patient with cholangiocarcinoma.

Authors:  Alaa M Ali; Aram Barbaryan; Teresita Zdunek; Maliha Khan; Prakruthi Voore; Aibek E Mirrakhimov
Journal:  J Gastrointest Oncol       Date:  2014-04

Review 8.  Tumour lysis syndrome: implications for cancer therapy.

Authors:  Denish Mika; Sabrina Ahmad; C Guruvayoorappan
Journal:  Asian Pac J Cancer Prev       Date:  2012

9.  Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome.

Authors:  Márcio Soares; Guilherme A Feres; Jorge I F Salluh
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

Review 10.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
View more
  1 in total

1.  Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report.

Authors:  Yadong Wang; Tiange Wang; Jianchao Xue; Ziqi Jia; Xinyu Liu; Bowen Li; Ji Li; Xiaoguang Li; Weiwei Wang; Zhongxing Bing; Lei Cao; Zhili Cao; Naixin Liang
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.